TrialBreast cancer research and treatment2014

A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007.

Kathy D Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.